Yüklüyor......
Ethics of a partially effective dengue vaccine: Lessons from the Philippines
Dengvaxia, a chimeric yellow fever tetravalent dengue vaccine developed by SanofiPasteur is widely licensed in dengue-endemic countries. In a large cohort study Dengvaxia was found to partially protect children who had prior dengue virus (DENV) infections but sensitized seronegative children to brea...
Kaydedildi:
| Yayımlandı: | Vaccine |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier Ltd.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7347470/ https://ncbi.nlm.nih.gov/pubmed/32654899 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2020.06.079 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|